267 related articles for article (PubMed ID: 7797196)
1. Hepatosinusoidal leukaemia/lymphoma consisting of Epstein-Barr virus-containing natural killer cell leukaemia/lymphoma and T-cell lymphoma; mimicking malignant histiocytosis.
Ohshima K; Kikuchi M; Mizuno S; Akashi K; Moriyama K; Yoneda S; Takeshita M; Shibata T
Hematol Oncol; 1995; 13(2):83-97. PubMed ID: 7797196
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus (EBV)-induced CD30+ natural killer cell-type malignancy resembling malignant histiocytosis: malignant transformation in chronic active EBV infection associating hypogammaglobulinemia.
Tsutsumi Y; Tang X; Yamada T
Pathol Int; 1997 Jun; 47(6):384-92. PubMed ID: 9211526
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-containing T-cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosis.
Su IJ; Hsu YH; Lin MT; Cheng AL; Wang CH; Weiss LM
Cancer; 1993 Sep; 72(6):2019-27. PubMed ID: 8395969
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of systemic extra-nodal Epstein-Barr virus-associated lympho-histiocytic tumor--ten autopsy cases of human immunodeficiency virus-negative Japanese.
Ohshima K; Kobari S; Kuroiwa S; Nakanishi K; Shibuya T; Nagafuchi S; Suzumiya J; Takeshita M; Kikuchi M
Pathol Res Pract; 1997; 193(4):257-65. PubMed ID: 9258951
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological study of severe chronic active Epstein-Barr virus infection that developed in association with lymphoproliferative disorder and/or hemophagocytic syndrome.
Ohshima K; Suzumiya J; Sugihara M; Nagafuchi S; Ohga S; Kikuchi M
Pathol Int; 1998 Dec; 48(12):934-43. PubMed ID: 9952337
[TBL] [Abstract][Full Text] [Related]
6. Genotypic and phenotypic alterations in Epstein-Barr virus-associated lymphoma.
Ohshima K; Suzumiya J; Kanda M; Haraoka S; Kawasaki C; Shimazaki K; Kikuchi M
Histopathology; 1999 Dec; 35(6):539-50. PubMed ID: 10583578
[TBL] [Abstract][Full Text] [Related]
7. Malignant histiocytosis derived from a common histiocyte clone in a patient with chronic Epstein-Barr virus infection.
Ohshima K; Fujisaki T; Nagafuchi S; Niho Y; Kobari S; Kikuchi M
Leuk Lymphoma; 1995 Apr; 17(3-4):355-60. PubMed ID: 8580809
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus infection in the neoplastic and nonneoplastic cells of lymphoid malignancies.
Teramoto N; Sarker AB; Tonoyama Y; Yoshino T; Hayashi K; Takahashi K; Akagi T
Cancer; 1996 Jun; 77(11):2339-47. PubMed ID: 8635105
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection.
Tsuchiyama J; Yoshino T; Mori M; Kondoh E; Oka T; Akagi T; Hiraki A; Nakayama H; Shibuya A; Ma Y; Kawabata T; Okada S; Harada M
Blood; 1998 Aug; 92(4):1374-83. PubMed ID: 9694726
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese.
Nakamura S; Katoh E; Koshikawa T; Yatabe Y; Nagasaka T; Ishida H; Tokoro Y; Koike K; Kagami Y; Ogura M; Kojima M; Nara Y; Mizoguchi Y; Hara K; Kurita S; Seto M; Suchi T
Pathol Int; 1997 Jan; 47(1):38-53. PubMed ID: 9051691
[TBL] [Abstract][Full Text] [Related]
11. Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management.
Su IJ; Wang CH; Cheng AL; Chen RL
Leuk Lymphoma; 1995 Nov; 19(5-6):401-6. PubMed ID: 8590839
[TBL] [Abstract][Full Text] [Related]
12. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
[TBL] [Abstract][Full Text] [Related]
13. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
Chan JK; Sin VC; Wong KF; Ng CS; Tsang WY; Chan CH; Cheung MM; Lau WH
Blood; 1997 Jun; 89(12):4501-13. PubMed ID: 9192774
[TBL] [Abstract][Full Text] [Related]
14. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage.
Chiang AK; Chan AC; Srivastava G; Ho FC
Int J Cancer; 1997 Nov; 73(3):332-8. PubMed ID: 9359478
[TBL] [Abstract][Full Text] [Related]
15. EBV-NK cells interactions and lymphoproliferative disorders.
Kanegane H; Yachie A; Miyawaki T; Tosato G
Leuk Lymphoma; 1998 May; 29(5-6):491-8. PubMed ID: 9643562
[TBL] [Abstract][Full Text] [Related]
16. A study of the possible etiologic association of Epstein-Barr virus with reactive hemophagocytic syndrome in Hong Kong Chinese.
Wong KF; Chan JK; Lo ES; Wong CS
Hum Pathol; 1996 Nov; 27(11):1239-42. PubMed ID: 8912837
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
Hue SS; Oon ML; Wang S; Tan SY; Ng SB
Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
[TBL] [Abstract][Full Text] [Related]
18. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
Chiang AK; Tao Q; Srivastava G; Ho FC
Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467
[TBL] [Abstract][Full Text] [Related]
19. Intestinal T-cell and natural killer-cell lymphomas in Taiwan with special emphasis on 2 distinct cellular types: natural killer-like cytotoxic T cell and true natural killer cell.
Tung CL; Hsieh PP; Chang JH; Chen RS; Chen YJ; Wang JS
Hum Pathol; 2008 Jul; 39(7):1018-25. PubMed ID: 18482744
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus in T and natural killer (NK) cell non-Hodgkin's lymphomas.
Kanavaros P; Briere J; Emile JF; Gaulard P
Leukemia; 1996 Jun; 10 Suppl 2():s84-7. PubMed ID: 8649060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
